EXAM 3 Flashcards

(111 cards)

1
Q

Diabetes type 1

A
  • autoimmune dysfunction
  • an inadequate production of insulin
  • early-onset (age < 30 years), genetic predisposition, race/ethnicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diabetes type 2

A
  • body cell’s cannot respond to the production of insulin regardless of making it.
  • more common
    -obesity, age>30 years, hypertension, smoking alcohol, HDL<35 mg/Dl or triglycerides> 250 mg/dl, or history of gestational diabetes or babies over 9 pounds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Functions of insulin

A

❖ Transports and metabolizes glucose for
energy
❖ Stimulates storage of glucose in the liver
and muscle as glycogen
❖ Signals the liver to stop the release of
glucose
❖ Enhances storage of dietary fat in adipose
tissue
❖ Accelerates transport of amino acids into
cells
❖ Inhibits the breakdown of stored glucose,
protein, and fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

LADA

A

-Subtype of diabetes in which progression of autoimmune beta cell destruction in the pancreas is slower than in types 1 and 2 diabetes
-clinical manifestation of LADA shares the features of types 1 and 2 diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Metabolic syndrome

A

-Elevated waist circumference (greater or equal to 88 cm for women, greater or equal to 102 cm for men)
-Elevated triglycerides (greater or equal to 150 mg/dl) or drug treatment for elevated triglycerides
-low HDL cholesterol (< 40 mg/dl for men, <50 mg/dl for women) or drug treatment for low HDL
-elevated blood pressure (systolic greater or equal to 130 mm Hg or diastolic greater or equal to 85 mm Hg) or hypertensive drug treatment
-elevated fasting glucose (greater or equal to 100 mg/dl) or drug treatment for elevated glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Diabetes mellitus type 1 S/S

A
  • Polyuria, polydipsia, polyphagia
    -fatigue, weakness, vision changes, tingling or numbness in hands or feet, dry skin, skin lesions or wounds that are slow to heal, recurrent infections, fruity breath
    -kussmaul respiration
    -type 1 may have sudden weight loss, headache, nausea, vomiting or abdominal pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Type 1 diabetes features

A

Onset: sudden
Age at onset: mostly in children
Body habits: Thin or normal
Ketoacidosis: common
Auto antibodies: usually present
Endogenous insulin: low or absent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type 2 diabetes

A

Onset: gradual
Age at onset: Mostly in adults
Body habits: Often obese
Ketoacidosis: Rare
Auto antibodies: absent
Endogenous insulin: Normal, decreased or increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Optimal HgbA1c levels for management of diabetes

A

less than 6.5%-8% would be optimal
Target goal: 7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Insulin Therapy

A

Rapid acting- lispro
short acting - regular insulin
Intermediate acting - NPH insulin
Long acting: Glargine insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nursing actions for diabetes

A

-observe client perform administration
-monitor for hypoglycemia
-Dosages can be adjusted for exercise, fasting procedures, diet
-Rotate the injection site to prevent lip hypertrophy
- inject at 90 angle (45 if thin)
-no need to aspirate for blood
-rapid or short acting (clear) drawn up first, then long acting (cloudy)
-wear medi alert

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Methods of insulin delivery

A

-Traditional subq injections
-Insulin pens
-jet injectors
-Insulin pumps
-Future: implantable insulin pumps, artificial pancreas systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Complications of insulin therapy

A

-local allergic reactions
-systemic allergic reactions
-insulin lipodystrophy
-resistance to injected insulin
-hypoglycemia
-Morning hyperglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

hypoglycemia s/s

A

-shaky
-fast heartbeat
-sweaty
-dizzy
-anxious
-hungry
-blurry vision
-weak or tired
-headache
-nervous or upset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hyperglycemia s/s

A

-extreme thirst
-frequent urination
-dry skin
-hunger
-blurred vision
-drowsiness
-nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

management of hypoglycemia

A

-give 15 to 20 g of fast-acting, concentrated carbohydrate
-three or four glucose tablets
-glucose gel, 6-10 hard candies
-4 to 6 ounces of juice or regular soda (not diet soda)
-Emergency measures; if the patient cannot swallow or is unconscious
-subq or im glucacon (1 mg)
-25 to 50 ml of 50% dextrose solution IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Oral antidiabetic agents focuses

A

-used for patients with type 2 diabetes who require more than diet and exercise alone
-combinations of oral drugs may be used
-major side effect: hypoglycemia
-Nursing interventions: monitor blood glucose for hypoglycemia and other potential side effects
-patient education

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Biguanide (metformin)

A

counter insulin resistance (especially decrease hepatic glucose output)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

sulfonylureas (glimepiride, glidazide, glyburide/gilbenadmine, glipizide)

A

Stimulate insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Meglitinides (repaglinide, nateglinide)

A

Simulate insulin secretion (faster onset and shorter duration of action than sulfonylureas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Gliptins (sitagliptin, vildagliptin, saxagliptin)

A

Increase prandial insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

thiazolidinediones (pioglitazone, rosiglitazone)

A

increase insulin sensitivity (especially increase peripheral glucose utilization)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

a-Glucosidase inhibitors (acarbose, miglitol, voglibose)

A

Slow rate of carb digestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Exercise

A

-Lower blood glucose-exercise only when levels are between 80-250
-If more than 1 hour passed since eating and planning high intensity work out, consume a carbohydrate snack first
-Ketones in urine- don’t
-Check BS more often
-Benefits: Aids in weight loss, easing stress, and maintaining a feeling of well-being. It also lowers cardiovascular risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Exercise precautions
-insulin normally decreases with exercise; patients on exogenous insulin should eat a 15 g carbohydrate snack before moderate exercise to prevent hypoglycemia -patients with type 2 diabetes not taking insulin or an oral agent may not need extra food before exercise -potential post-exercise hypoglycemia -need to monitor bg levels more often gerontologic considerations
26
Foot care
-Wash daily -Dry well especially between toes -feel for bumps or temperature changes -look between toes; check each toenail -file toenails straight across -check for dry cracked skin -examine bottom of the feet -track what you find
27
SICK days
(SUGAR): check your bg level ever 2 to 3 hrs necessary (INSULIN): always continue to take ur insulin even when you are sick to avoid DKA (CARBS): Make sure you take in enough carbs and drink enough fluids. If your glucose level is high, stick with sugar-free drinks. If ur glucose level is low, drink carb-containing drinks. -(KETONES): Check ur blood or urine ketone levels every 4 hrs. Take rapid-acting insulin if ketones are present. Remember to drink plenty of water to flush out ketones out of ur system.
28
Acute complications of Diabetes
-hypoglycemia -DKA -Hyperglycemic hyperosmolar syndrome (HHS) -Comparison of DKA and HHS
29
DKA (Type 1) s/s
-Dry and high sugar 250-500 + -Keytones and Kussmaul resp. -Abominal pain -Acidosis Metabolic ph 7.35 or less
30
HHNS (type 2) s/s
-highest sugar OVER 600+ -Higher fluid loss (extreme dehydration) - Head Change-Neurological Manifestations "Confusion" - NO abdominal Pain, NO ketones (NO ACID, NO KUSSMAUL) -Slower onset and stable potassium
31
DKA
-Absence or inadequate amount of insulin resulting in abnormal metabolism of carb, protein, and fat -Clinical features - hyperglycemia, dehydration, Acidosis, 3 Ps, Abdominal pain, N/V, profound weakness, blurred vision, headache, orthostatic hypotension, fruity breath, mental status changes
32
Common causes of DKA
-infection (pneumonia, UTI, skin, abdominal) -Infraction (MI, stroke, bowel infarction) -infant on board (pregnancy) -indiscretion (dietary nonadherence) -insulin deficiency (insulin pump failure or nonadherence)
33
LAB assessment of DKA
-Blood glucose levels between 250-800 mg/dl -Ketoacidosis low serum bicarbonate, low pH; low PCO2 -electrolytes vary due to degree of dehydration -BUN: greater than 30 -creatinine greater than 1.5 -Hct: Increased -NA: below, within or above; K: Within or above Ketones in blood and urine
34
hyperglycemic hyperosmolar syndrome
-hyperosmolar hyperglycemia is caused by a lack of sufficient insulin; ketosis is minimal or absent -hyperglycemia (greater than 600) causes osmotic diuresis, loss of water and electrolytes, hypernatremia, and increased osmolality = profound dehydration Manifestations: 3 Ps, orthostatic hypotension, Tachycardia, weight loss, neurologic signs caused by cerebral dehydration
35
Lab assessment of HHS
-Blood glucose levels greater than 600 mg/dL -ABGs: absence of acidosis; pH greater than 7.4; bicarb greater than 20mEq/L -Electrolytes vary due to the degree of dehydration -BUN: greater than 30 -Creatinine greater than 1.5 -HCT: increased -NA: normal or below -K: normal to high d/t dehydration -Ketones absent
36
Long-term complications of diabetes
-Macrovascular (accelerated atherosclerotic changes) * coronary artery disease, cerebrovascular disease, stroke, MI, peripheral vascular disease -Microvascular *microangiopathy; diabetic retinopathy, nephropathy -Neuropathic *peripheral neuropathy, autonomic neuropathies, hypoglycemic unawareness, neuropathy, sexual dysfunction
37
Pituitary gland
* The master gland * Regulated by the hypothalamus * Divided into two lobes * Posterior pituitary * Anterior pituitary
38
Anterior pituitary Disorders
 ACTH- Adrenocorticotropic hormone  Too much → Cushing’s disease  Too little → Addison's disease  GH- Growth hormone  Too much → gigantism and acromegaly  Too little → dwarfism
39
Posterior pituitary Disorders
 ADH- Antidiuretic hormone  Too much → SIADH  Too little → DI
40
Adrenal Gland
 Adrenal medulla - Functions as part of the autonomic nervous system  Catecholamines: epinephrine and norepinephrine  Adrenal cortex - Glucocorticoids - Cortisol affects glucose, protein and fat metabolism; responds to stress; affects the immune system  Mineralocorticoids - Aldosterone increases sodium absorption and potassium excretion in the kidney
41
Blood Cortisol levels
 Higher levels in the morning - Peak between 0400 and 0800  Lowest levels around midnight or 3 to 5 hours after the onset of sleep  The 4 pm lab value should be 1/3 to 2/3 of the 8 am value  8:00 am: 5 to 23 mcg/dL  4:00 pm: 3 to 13 mcg/dL
42
Addison's disease (Adrenocortical insufficiency)
 Damage or dysfunction of the adrenal cortex → decreased aldosterone and cortisol
43
Primary Addison's disease
 Idiopathic autoimmune dysfunction- most common  TB  Histoplasmosis  Adrenalectomy  Cancer metastasis  Radiation
44
Secondary Addison's Disease
 Not producing enough pituitary hormone: tumors, inflammation, etc.  Pituitary cancer  Radiation to the brain  Steroid withdrawal
45
Addison's disease clinical manifestations
 Weakness & fatigue (lack of energy, lethargy, tiredness)  Muscle weakness  Loss of body hair  Hyperpigmentation of the skin & mucous membranes  Low mood (mild depression) or irritability.  Loss of appetite & intentional weight loss.  Increased thirst &craving for salty foods  Nausea & vomiting  Constipation or diarrhea  Abdominal pain  Low blood sugar  Reproductive- ED, irregular menstrual cycle  Low BP (acute adrenal insufficiency)
46
Addison's LAB TESTS
 Increased K  Increased WBC  Decreased Na  Increased Calcium  Increased BUN/creatinine  Blood glucose- normal to decreased  Blood/salivary cortisol  ACTH stimulation test(provocation test)
47
Adrenal Insufficiency Nursing care
-prevent circulatory shock -Keep room temperature warm -observe for dehydration -monitor for hyperkalemia and hypoglycemia -Administer hydrocortisone -Administer fludrocortisone -AVOID STRESS AND GIVE 15 G CARB SNACK
48
ACTH SIM TEST
 Rapid test 1. Obtain a baseline blood cortisol level then wait 30 minutes 2. After 30 minutes administer ACTH 3. Check blood levels at 30 min and 1 hour  Results - If cortisol levels do not rise indicates primary adrenal insufficiency - If cortisol levels increase > 7 mg/dL indicates secondary adrenal insufficiency - An expected response is an increase cortisol after administration
49
Addisonian crisis
 Life-threatening event  The body’s cortisol need is greater than supply (sudden drop in cortisol)  If left untreated can lead to death  Rapid onset of symptoms consistent with Addison’s disease  Triggering factors - Sepsis/ infection - Trauma - Stress - MI, surgery, anesthesia, hypothermia, volume loss, hypoglycemia - Adrenal hemorrhage - Steroid withdrawal
50
Cushing's disease
 Caused by overexcretion of adrenal cortex hormones - Aldosterone - Cortisol - Androgens  Cushing’s disease results from a tumor in the pituitary gland  Cushing’s syndrome results from long -term use of glucocorticoids
51
Cushing's disease s/s
-Moon face -Purple striae -osteoporosis -hyperglycemia -thinning bald head -Males (gynecomastia) -HTN, tachycardia -hypokalemia -hypocalcemia -hypernatremia
52
Dexamethasone Suppression test
-Rapid testing- high dose -Prolong testing- low dose (Non-suppression of cortisol indicates Cushing's disease)
53
Cushing's nursing management
 Monitor I&Os, daily weights  Assess for hypervolemia-edema, distended neck veins, SOB, hypertension, tachy  Maintain safe environment to decrease the risk of fractures and skin trauma  Turn and reposition the client every 2 hours  Monitor for and protect against skin breakdown and infection  Monitor WBC daily
54
Treatment
 Ketoconazole - Adrenal corticosteroid inhibitor in high doses - Monitor LFTs for toxicity - Hydrocortisone can be used with it  Mitotane - Produces selective destruction of adrenocortical cells - Used for inoperable adrenal carcinoma (lifetime) - Monitor LFTs and kidney function tests  Chemotherapy - Used for Cushing’s caused by a tumor
55
Cushing Client education
 Eat foods high in calcium and vitamin D  Avoid infection  Carry emergency card about steroid use  Report black, tarry stools
56
Thyroid Gland
 T3 and T4 are regulated by the anterior pituitary gland  T3 and T4 affect all body systems by regulating overall body metabolism, energy production, and controlling tissue use of fats, protein, and carbohydrates  Dietary intake of protein and iodine is necessary for thyroid hormone production
57
Hypothyroidism
 Inadequate amounts of circulating thyroid hormones T3 and T4  Primary hypothyroidism caused by:  Hashimoto’s thyroiditis  Autoimmune disease  Most common cause in adults  Loss of thyroid gland  Use of certain medications  Lithium, amiodarone
58
Hypothyroidism s/s
 Fatigue, lethargy  Irritability  Hair loss, brittle nails, dry skin  Paresthesia's of fingers  Husky voice, hoarseness  Intolerance to cold  Low body temperature  Bradycardia, hypotension, dysrhythmias  Weight gain without an increase of caloric intake
59
Hypothyroid management
 Levothyroxine -Synthetic thyroid hormone replacement -Use caution with older adults- start dose low and increase gradually -Monitor for chest pain, SOB -Dose can be increased every 2 to 3 seeks -Take on an empty stomach in the morning -Monitor for manifestations of hyperthyroidism -Treatment is lifelong
60
Myxedema Coma
 Extreme symptoms of severe hypothyroidism  Life-threatening condition  Occurs when hypothyroidism is untreated, poorly managed, or can be caused by stress
61
Hyperthyroidism
 Excessive circulating thyroid hormones  Exaggerates normal body functions and produces a hypermetabolic state  Graves' disease - Autoimmune disorder - Most common cause of hyperthyroidism  Thyroiditis  Toxic adenoma  Exogenous- excessive dose of thyroid hormones  Affects women 8X more frequently than men  Most common during 20s and 40s
62
hyperthyroidism s/s
 Nervousness, irritability, hyperactivity  Emotional liability  Decreased attention span  Weakness, easily fatigued, exercise intolerance  Heat intolerance  Palpitations and tachycardia  Skin is flushed, salmon color, warm, soft, and moist
63
Exophtmalmos
 Seen with Graves Disease  Wide open eyes  Patient is at risk for injury to the cornea  Priority is to protect the patient’s eyes/cornea
64
Hyperthyroidism management
 Radioactive iodine therapy - Thyroid cells exposed to the radioactive iodine are destroyed - Results in reduction of hyperthyroid state and inevitably hypothyroidism - The degree of thyroid destruction varies and can require lifelong thyroid replacement  Thionamides (methimazole and propylthiouracil/PTU) inhibit the production of thyroid hormones - Monitor for symptoms of hypothyroidism - Monitor CBC, LFTs - With meals
65
Thyroid storm
 Sudden surge of large amounts of thyroid hormones into the blood stream  Fatal if untreated  Caused by uncontrolled hyperthyroidism, infection, trauma, emotional stress, DKA, digitalis toxicity, and thyroidectomy  S/S - High fever - Tachycardia, HTN, chest pain, palpations, dyspnea - Delirium - Vomiting, abdominal pain
66
Diabetes Insipidus
 Disorder of the posterior pituitary gland  Often seen as a complication of brain surgery, head trauma, brain tumor  Deficiency of ADH reduces the ability of the distal renal tubules in the kidneys to collect and concentrate urine → very large dilute urine output, even if the pt’s fluids are restricted S/S: polydipsia, hypovolemia RISK FOR HYPOVOLEMIC SHOCK
67
Types of DI
-Primary neurogenic: lack of ADH production or release caused by defects in the hypothalamus or pituitary gland -Secondary neurogenic: lack of ADH production or release caused by infection, tumors, trauma, or brain surgery -Nephrogenic: Renal tubules that do not react to ADH caused by genetics, kidney damage, or medications
68
DI LAB TESTS
(URINE TESTING) -DILUTE -DECREASE IN URINE SPECIFIC GRAV, URINE OSMOLARITY, URINE SODIUM, and URINE POTASSIUM (BLOOD TESTING) -CONCENTRATED -INCREASE IN BLOOD OSMOLARITY, SERUM SODIUM, SERUM POTASSIUM
69
DI MANAGEMENT
 Desmopressin - Treats neurogenic DI - Synthetic ADH - Routes- intranasal, PO, or parenterally - Increases water absorption from the kidneys and decreases Urine Output  Prostaglandin inhibitors and thiazide diuretics  Treats nephrogenic DI  Life long- vasopressin  Daily weight
70
SIADH
 Excessive release of ADH (vasopressin), secreted by the posterior lobe of the pituitary gland  Excess ADH → renal reabsorption of water and suppression of RAAS → water intoxication, cellular edema, dilutional hyponatremia → fluid shifts within compartments cause decreased blood osmolarity -RISK FOR SEIZURES
71
SIADH RISK FACTORs
 Malignant tumors  Increased intrathoracic pressure  Head injury, meningitis, stroke  TB  Medications (chemo, TCAs, SSRIs, opioids, fluoroquinolone antibiotics)
72
SIADH clinical manifestations
 Personality changes  Hostility  Sluggish DTRs  NVD  Oliguria with dark urine
73
SIADH LAB TESTs
(URINE TESTING) -concentrated -Urine sodium and urine osmolarity increased (BLOOD TESTING) -Dilute -Blood sodium and blood osmolarity decreased
74
MED FOR SIADH
-Tetracycline: stimulates urinary flow -Tolvaptan, conivaptan: used only in acute settings -Furosemide: used with caution (Can cause NA excretion) WATCH FOR HYPONATREMIA -Hypertonic saline: Used in severe cases
75
Normal ABG levels
PH: 7.35-745 PCO2: 35-45 HCO3: 22-26
76
Metabolic Acidosis: Clinical Manifestations
DUE TO RENAL FAILURE  Neurologic: Headache, Confusion, Drowsiness  Increased respiratory rate and depth (Kussmaul respirations)  Vital signs: Decreased blood pressure, brady, weak pulses  Decreased cardiac output  Dysrhythmias  Shock  Patient may be asymptomatic until bicarbonate is 15 meq/L or less
77
Metabolic Alkalosis: Clinical Manifestations
DUE TO VOMITING OR GASTRIC SUCTION  Symptoms related to decreased calcium  Respiratory depression  Tachycardia  BP- hypotensive or normo  Symptoms of hypokalemia- PVCs  Neurologic- numbness, tingling, weakness, hyperreflexia
78
Respiratory Acidosis: Clinical manifestations
CAUSES:  Respiratory depression: opioids, poisons  Increased ICP, Brain tumors, cerebral aneurysm, stroke  Inadequate chest expansion due to muscle weakness, pneumothorax,  Chronic resp acidosis- sleep apnea, obesity  PE, ARDS, trauma (MANIFESATIONS)  With chronic respiratory acidosis, the body may compensate and may be asymptomatic  Symptoms may include a suddenly increased pulse, respiratory rate, and BP  Bradycardia and hypotension as acidosis worsens  Dysthymia- Ventricular fib
79
Respiratory Alkalosis: Clinical manifestations
Always due to hyperventilation  Tachypnea- rapid and deep respirations  Tachycardia dysrhythmias: ventricular/atrial  Neurologic - Lightheadedness - Inability to concentrate - Numbness and tingling - Tinnitus: - Sometimes loss of consciousness
80
Epistaxis
-HEMORRHAGE FROM THE NOSE -ANTERIOR SEPTUM, MOST COMMON SITE -SERIOUS PROBLEM, MAY RESULT IN AIRWAY COMPROMISE OR SIGNIFICANT BLOOD LOSS -RISK FACTORS: FACIAL INJURY/TRAUMA, PHYSICAL OR CHEMICAL MUCOSAL IRRITATION, SINUSITIS, ALLERGIC RHINITIS, INFECTIOUS RHINITIS, NASAL TUMORS, TEMPERATURE, AND HUMIDITY. BLEEDING DISORDERS, ANTICOAGULANTS
81
Nursing Management of Epistaxis
 Airway, breathing, circulation  Vital signs, possible cardiac monitoring and pulse oximetry  Reduce anxiety
82
URIs
 An infection of the mucous membranes of the nose, sinuses, pharynx, upper trachea, or larynx  Types:  Rhinitis and rhinosinusitis: acute, chronic, bacterial, viral
83
Rhinitis and Rhinosinusitis
 Inflammation and irritation of the mucous membranes of the nose and sinuses.  Acute or chronic, and allergic or nonallergic  Causes: viral or bacterial or allergens.
84
Rhinitis and Rhinosinusitis Clinical manifestations
 Rhinorrhea (excessive nasal drainage, runny nose)  Nasal congestion  Nasal discharge (purulent with bacterial rhinitis)  Sneezing  Itchy, watery eyes
85
Medical/Nursing management for Rhinitis and Rhinosinusitis
 Antihistamines- most common treatment and are given for sneezing, pruritus, and rhinorrhea. Brompheniramine/pseudoephedrine- an example of combination antihistamine/decongestant medications.  Oral decongestant agents may be used for nasal obstruction.  Allergic rhinitis- avoid or reduce exposure to allergens/irritants.  Education in the use of all medications.  Vitamins- echinacea, vitamin c, zinc
86
Pharyngitis
 An inflammation of the pharynx, resulting in a sore throat.  Uncomplicated viral infections usually subside promptly, within 3 to 10 days after onset.  If caused by bacteria, is a more severe illness.
87
Pharyngitis Clinical manifestations
 fiery-red pharyngeal membrane and tonsils  lymphoid follicles that are swollen and flecked with white-purple exudate,  enlarged and tender cervical lymph nodes
88
Influenza
 Severe headache  Chills  Fatigue, weakness  Fever  Hypoxia (avian)  Severe diarrhea (Avian) MEDS:  Amantadine, Rimantadine, Ribavirin
89
Pathophysiology of laryngeal cancer
 Malignant cancer cells form in the larynx  Most common: well-differentiated squamous cell carcinoma (95%)  *Supraglottic: above vocal cords  *Glottis: area of vocal cords  Subglottic: below vocal cords
90
laryngeal cancer clinical manifestations
Early symptoms  Sore throat  Voice changes, hoarseness  Pain with swallowing  Nagging cough that won’t go away Late symptoms:  Mass in neck  Weight loss  Dysphagia  Airway compromise
91
Asthma
Chronic disorder of airways that result in intermittent and reversible airflow obstruction of the bronchioles. Obstruction occurs either by inflammation or airway hyperresponsiveness.
92
Risk factors for Asthma
 Genetics-inherited component is complex - Atopy—genetic predisposition to develop IgE-mediated response to common allergens is a major risk factor  Smoking - Second-hand smoke Environmental allergies
93
Asthma clinical manifestations
 Wheezing, cough, chest tightness, silent chest
94
Medical/Nursing managements
 Albuterol- watch for tremors & tachy  Ipratropium- observe for dry mouth ,increase fluid intake, report HA*, blurred vision* or palpitations* (toxicity)  Theophylline- monitor for toxicity. Tachy, nausea & diarrhea.  High fowlers: 90% to maximize ventilations  Oxygen with humidification to loosen secretions  Face mask
95
Status asthmaticus
 Extreme acute asthma attack characterized by hypoxia, hypercapnia, and acute respiratory failure; lifethreatening  Wheezing, labored breathing, chest tightness, increased shortness of breath, distended neck veins, use of accessory muscles and sudden inability to speak  Without treatment leads to hypotension, bradycardia, and respiratory/cardiac arrest
96
Chronic Bronchitis
-overweight and cyanotic, peripheral edema ❖Inflammation of the bronchi and bronchioles due to chronic exposure to irritants. ❖Cough and sputum production for at least 3 months in each of 2 consecutive years ❖Ciliary function is reduced, bronchial walls thicken, bronchial airways narrow, and mucous may plug airways
97
Emphysema
-severe dyspnea, older and thin  Loss of lung elasticity & hyperinflation of lung tissue.  Causes a destruction of the alveoli, increased air spaces leading to decreased surface area for gas exchange, carbon dioxide retention and respiratory acidosis.
98
Right sided heart failure
 Respiratory Infection - Result from increased mucous production & poor oxygen levels -cor pulmonale
99
bronchiectasis
❖ Bronchiectasis is a chronic, irreversible dilation of the bronchi and bronchioles ❖ Caused by: ▪ Airway obstruction, pulmonary infections ▪ Diffuse airway injury ▪ Genetic disorders ▪ Abnormal host defenses ▪ Idiopathic causes
100
Bronchiectasis clinical manifestations/medical management
 Chronic cough  Purulent sputum in copious amounts  Clubbing of the fingers  Postural drainage  Chest physiotherapy  Smoking cessation  Antimicrobial therapy  Bronchodilators and mucolytics
101
cystic fibrosis
-Cystic fibrosis (CF) is a genetic disorder that causes problems with breathing and digestion (autosomal recessive) -Genetic mutation changes chloride transport which leads to thick, viscous secretions in the lungs, pancreas, liver, intestines, and reproductive tract
102
Medical management of CF
-Chronic: control of infections; antibiotics -Acute: aggressive therapy involves airway clearance and antibiotics based on results of sputum cultures -Anti-inflammatory agents -Corticosteroids; inhaled, oral, IV during exacerbations -Inhaled bronchodilators -Oral pancreatic enzyme supplementation with meals -Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are a new class of drugs and help to improve function of the defective CFTR protein
103
Pneumonia
Inflammation of the lung parenchyma caused by various microorganisms, including bacteria, mycobacteria, fungi, and viruses
104
Clinical Manifestations of Pneumonia
 Pleuritic chest pain (sharp)when you breathe or cough  Confusion or changes in mental awareness (in adults age 65 and older)  Cough, which may produce purulent, blood-tinged  Fatigue  Fever, sweating and shaking chills -crackles, wheezing
105
Pulmonary Tuberculosis
 Caused by Mycobacterium tuberculosis bacillus (TB)  Spreads by airborne transmission through droplets to primarily lungs then moves to other parts of the body such as the kidneys, bones, and cerebral cortex via blood.
106
clinical manifestations of TB
 Low‐grade fever  Cough; nonproductive or mucopurulent lasting longer than 3 weeks  Night sweats, fatigue, weight loss  Cough may be nonproductive, or mucopurulent sputum may be expectorated
107
Mantoux test
Used to see if one is positive with TB
108
Medications for TB
 Rifampin (RIF) 10 mg/kg (600 mg maximum daily)  SE: Hepatitis, febrile reaction, purpura (rare), nausea, vomiting  Bactericidal/bacteriostatic antibiotic  Pyrazinamide 15–30 mg/kg (2 g maximum daily)  SE: Hyperuricemia, hepatotoxicity, skin rash, arthralgias, GI distress  Bactericidal/bacteriostatic antibiotic
109
military TB
Usually affects the lungs, but almost any organ can be involved.  Symptoms  Headaches, neck stiffness, drowsiness (life threatening)  Pericarditis: dyspnea, swollen neck veins, pleuritic pain, hypotension
110
Chest tubes
 Function - Inserted into the pleural space todrain fluid, blood or air - Reestablish a negative pressure - Facilitate lung expansion - Restore normal intrapleural pressure.  Indications -Pneumothorax - Hemothorax - Post op drainage - Pleural effusion - Pulmonary empyema
111
MANIFESTATIONS FOR THOSE NEEDED FOR A CHEST TUBE
 Dyspnea  JVD  Hemodynamic instability  Pleuritic chest pain  Cough  Absent or reduced breath sounds on affected side  Dullness on percussion on the affected side (hemothorax, pleural effusion)  Asymmetrical chest wall motion